A single-amino-acid mutation in hepatitis C virus NS5A disrupts physical and functional interaction with the transcription factor HNF-1α

Journal of General Virology

Volumn 96, Issue 8, 2015, Pages 2200-2205

  Matsui, Chieko ^a   Sianipar, Imelda Rosalyn ^a,b   Minami, Nanae ^a   Deng, Lin ^a   Hotta, Hak ^a   Shoji, Ikuo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DACLATASVIR; FK 506 BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; NONSTRUCTURAL PROTEIN 5A; VIRUS RNA; NS-5 PROTEIN, HEPATITIS C VIRUS; PROTEIN BINDING; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; GENOTYPE; HEPATITIS C VIRUS; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VIRUS REPLICATION; CHEMISTRY; GENETICS; HEPACIVIRUS; HEPATITIS C; METABOLISM; MISSENSE MUTATION; PROMOTER REGION; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

HEPATITIS C VIRUS;

HEPACIVIRUS; HEPATITIS C; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MUTATION, MISSENSE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84939231249     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.000179     Document Type: Article

References (21)

1. Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S. & other authors (2013). Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology 57, 964-973.
2. Blight, K. J., McKeating, J. A., Marcotrigiano, J. & Rice, C. M. (2003). Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77, 3181-3190
3. Deng, L., Shoji, I., Ogawa, W., Kaneda, S., Soga, T., Jiang, D. P., Ide, Y. H. & Hotta, H. (2011). Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 85, 8556-8568
4. Dong, B., Li, H., Singh, A. B., Cao, A. & Liu, J. (2015). Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1a protein expression through the ubiquitin-proteasome degradation pathway. J Biol Chem 290, 4047-4058
5. Gao, M. (2013). Antiviral activity and resistance of HCV NS5A replication complex inhibitors. Curr Opin Virol 3, 514-520
6. Kasai, D., Adachi, T., Deng, L., Nagano-Fujii, M., Sada, K., Ikeda, M., Kato, N., Ide, Y. H., Shoji, I. & Hotta, H. (2009). HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol 50, 883-894
7. Lai, S. W., Chen, P. C., Liao, K. F., Muo, C. H., Lin, C. C. & Sung, F. C. (2012). Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with antidiabetic therapy: a population-based cohort study. Am J Gastroenterol 107, 46-52
8. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
9. Love, R. A., Brodsky, O., Hickey, M. J., Wells, P. A. & Cronin, C. N. (2009). Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol 83, 4395-4403
10. Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G. & other authors (1999). Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29, 328-333
11. Matsui, C., Shoji, I., Kaneda, S., Sianipar, I. R., Deng, L. & Hotta, H. (2012). Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1a. J Virol 86, 12903-12911
12. Mehta, S. H., Brancati, F. L., Strathdee, S. A., Pankow, J. S., Netski, D., Coresh, J., Szklo, M. & Thomas, D. L. (2003). Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38, 50-56.
13. Negro, F. (2011). Mechanisms of hepatitis C virusrelated insulin resistance. Clin Res Hepatol Gastroenterol 35, 358-363.
14. Negro, F. & Alaei, M. (2009). Hepatitis C virus and type 2 diabetes. World J Gastroenterol 15, 1537-1547.
15. Okamoto, T., Omori, H., Kaname, Y., Abe, T., Nishimura, Y., Suzuki, T., Miyamura, T., Yoshimori, T., Moriishi, K. & Matsuura, Y. (2008). A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol 82, 3480-3489
16. Pawlotsky, J. M. (2013). NS5A inhibitors in the treatment of hepatitis C. J Hepatol 59, 375-382
17. Ray, S. C., Bailey, J. R. & Thomas, D. L. (2013). Hepatitis C virus. In Fields’ Virology, 6th edn., pp. 795-824. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins.
18. Shirane, M. & Nakayama, K. I. (2003). Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5, 28-37.
19. Shoji, I., Deng, L. & Hotta, H. (2011). Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders. Front Microbiol 2 (278)
20. Tellinghuisen, T. L., Marcotrigiano, J. & Rice, C. M. (2005). Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435, 374-379.
21. Wang, P., Kang, D., Cao, W., Wang, Y. & Liu, Z. (2012). Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 28, 109-122